These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12041693)

  • 1. Plasminogen activator activity in cortical granules of bovine oocytes during in vitro maturation.
    Rekkas CA; Besenfelder U; Havlicek V; Vainas E; Brem G
    Theriogenology; 2002 Apr; 57(7):1897-905. PubMed ID: 12041693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of urokinase type plasminogen activator on
    Roldán-Olarte M; Maillo V; Sánchez-Calabuig MJ; Beltrán-Breña P; Rizos D; Gutiérrez-Adán A
    Reproduction; 2017 Sep; 154(3):231-240. PubMed ID: 28667127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells.
    Park KW; Choi SH; Song XX; Funahashi H; Niwa K
    Biol Reprod; 1999 Jul; 61(1):298-304. PubMed ID: 10377062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of addition of tissue-type plasminogen activator in in vitro fertilization medium on bovine embryo development and quality.
    Krania F; Dovolou E; Rekkas CA; Theodosiadou EK; Pappas I; Amiridis GS
    Reprod Domest Anim; 2015 Feb; 50(1):112-20. PubMed ID: 25405906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasmin, plasminogen activators and a plasmin inhibitor on bovine in vitro embryo production.
    Papanikolaou T; Amiridis GS; Dimitriadis I; Vainas E; Rekkas CA
    Reprod Fertil Dev; 2008; 20(2):320-7. PubMed ID: 18255022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiloride selectively inhibits the urokinase-type plasminogen activator.
    Vassalli JD; Belin D
    FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.
    Sier CF; Verspaget HW; Griffioen G; Verheijen JH; Quax PH; Dooijewaard G; De Bruin PA; Lamers CB
    Gastroenterology; 1991 Dec; 101(6):1522-8. PubMed ID: 1955118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertilization outcome could be regulated by binding of oviductal plasminogen to oocytes and by releasing of plasminogen activators during interplay between gametes.
    Mondéjar I; Grullón LA; García-Vázquez FA; Romar R; Coy P
    Fertil Steril; 2012 Feb; 97(2):453-61. PubMed ID: 22177313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and regulation of tissue plasminogen activator activity in rat cumulus-oocyte complexes.
    Liu YX; NY T; Sarkar D; Loskutoff D; Hsueh AJ
    Endocrinology; 1986 Oct; 119(4):1578-87. PubMed ID: 3093195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
    Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
    Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of mouse cumulus cell-oocyte complex integrity before and after ovulation: plasminogen activator synthesis and matrix degradation.
    D'Alessandris C; Canipari R; Di Giacomo M; Epifano O; Camaioni A; Siracusa G; Salustri A
    Endocrinology; 2001 Jul; 142(7):3033-40. PubMed ID: 11416025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis.
    Lombardi ML; de Angelis E; Rossano F; Ruocco V
    Dermatology; 1993; 186(2):118-22. PubMed ID: 8428039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending prematuration with cAMP modulators enhances the cumulus contribution to oocyte antioxidant defence and oocyte quality via gap junctions.
    Li HJ; Sutton-McDowall ML; Wang X; Sugimura S; Thompson JG; Gilchrist RB
    Hum Reprod; 2016 Apr; 31(4):810-21. PubMed ID: 26908844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precocious loss of cortical granules during mouse oocyte meiotic maturation and correlation with an egg-induced modification of the zona pellucida.
    Ducibella T; Kurasawa S; Rangarajan S; Kopf GS; Schultz RM
    Dev Biol; 1990 Jan; 137(1):46-55. PubMed ID: 2104813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of tumor markers in uterine cancer (plasminogen activators, plasminogen activator inhibitors) using fibrin autography].
    Itoh Y; Nozaki S; Sawaguchi K; Masuda T; Yabushita H; Noguchi M; Miyata N; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1277-8. PubMed ID: 1431441
    [No Abstract]   [Full Text] [Related]  

  • 17. The plasminogen activation system in bovine milk: differential localization of tissue-type plasminogen activator and urokinase in milk fractions is caused by binding to casein and urokinase receptor.
    Heegaard CW; Rasmussen LK; Andreasen PA
    Biochim Biophys Acta; 1994 May; 1222(1):45-55. PubMed ID: 8186264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators, plasminogen activator inhibitor, and fibronectin in human granulosa cells and follicular fluid related to oocyte maturation and intrafollicular gonadotropin levels.
    Reinthaller A; Kirchheimer JC; Deutinger J; Bieglmayer C; Christ G; Binder BR
    Fertil Steril; 1990 Dec; 54(6):1045-51. PubMed ID: 2245829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of urokinase-type plasminogen activator receptor in bovine cumulus-oocyte complexes.
    García DC; Miceli DC; Rizo G; García EV; Valdecantos PA; Roldán-Olarte M
    Zygote; 2016 Apr; 24(2):230-5. PubMed ID: 25939353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
    Ganesh S; Sier CF; Heerding MM; van Krieken JH; Griffioen G; Welvaart K; van de Velde CJ; Verheijen JH; Lamers CB; Verspaget HW
    Br J Cancer; 1997; 75(12):1793-801. PubMed ID: 9192984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.